News | June 07, 2007

PET/CT: The Best Test for Women With Ovarian Cancer

June 8, 2007 – According to an Australian study released during the 54th Annual Meeting of the Society of Nuclear Medicine (SNM), an advanced molecular imaging technique has influenced the management of women with ovarian cancer, detected more site of disease and identified women whose disease was likely to progress.

The study shows that positron emission tomography (PET)/computed tomography (CT) imaging is a better test for patients with suspected recurrent ovarian cancer and is the preferred imaging technique.

“PET/CT, using fluorodeoxyglucose (FDG), detected many more sites of disease than were found with routine imaging both within and outside the abdomen,” said Michael J. Fulham, professor and clinical director of Medical Imaging at Sydney South West Area Health Service and head of the Department of PET and Nuclear medicine at Royal Prince Alfred Hospital in Sydney, Australia. “PET/CT influenced treatment decisions in 59 percent of the 90 women and identified those whose disease was more likely to progress within 12 months. Our findings also suggest that there is an opportunity for technology replacement, replacing routine CT of the abdomen and pelvis, with PET/CT with the radiotracer FDG, thus reducing costs and providing better answers for patients and referring doctors.”

Initial treatment is surgery followed by chemotherapy. If the cancer recurs, the treatment options include surgery or radiotherapy, if the disease is localized, and chemotherapy.

Related Content

Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and pat
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...